Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6899890 | PADAGIS US | Bioadhesive drug delivery system |
Apr, 2023
(2 months from now) | |
US9789057 | PADAGIS US | Pharmaceutical delivery system |
Dec, 2026
(3 years from now) |
Market Authorisation Date: 30 November, 2004
Treatment: Method of treating bacterial vaginosis
Dosage: CREAM;VAGINAL
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7374747 | MYLAN | Pharmaceutical foam |
Jan, 2024
(11 months from now) | |
US7141237 | MYLAN | Pharmaceutical foam |
Feb, 2024
(11 months from now) |
Market Authorisation Date: 22 October, 2004
Treatment: Treatment of acne vulgaris
Dosage: AEROSOL, FOAM;TOPICAL
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US11129896 | DARE | Topical formulations and treatments |
Sep, 2036
(13 years from now) |
Exclusivity | Exclusivity Expiration |
---|---|
New Product (NP) | Dec 7, 2024 |
Generating Antibiotic Incentives Now (GAIN) | Dec 7, 2029 |
Market Authorisation Date: 07 December, 2021
Treatment: Method of treating bacterial vaginosis by single dose administration of a clindamycin pharmaceutical gel formulation
Dosage: GEL;VAGINAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic